Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence
In recent years, the options in treatment of diabetes mellitus type 2 have substantially expanded (currently more than 40 molecules are approved), however, the number of patients with decompensation of diabetes for the period from 2003 to 2014 remains unchanged. In clinical guidelines injecting drug...
Guardado en:
Autores principales: | Olesya Y. Gurova, Valentin V. Fadeev, Ekaterina S. Maloletkina |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a28a6f67134498a832357c1716dc26a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
por: Victoriya N. Serebryakova, et al.
Publicado: (2021) -
Analysis of the factors that prevent adherence to treatment in patients with diabetes mellitus and the strategies that contribute to the improvement in adherence
por: Natalia V. Likhodey, et al.
Publicado: (2018) -
The effects of structured self-monitoring of blood glucose on therapeutic effectiveness and adherence in patients with type 2 diabetes mellitus initiating insulin treatment
por: Lyudmila Alexandrovna Suvorova, et al.
Publicado: (2013) -
Adherence to medicamentous therapy of type 2 diabetes mellitus: results of patient questionnaires
por: Elena Viktorovna Surkova, et al.
Publicado: (2009) -
Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
por: Vadim V. Klimontov, et al.
Publicado: (2020)